Skip to main content

Table 1 Patient characteristics

From: Recruitment pattern of the diaphragm and extradiaphragmatic inspiratory muscles in response to different levels of pressure support

Subject Age (years) Gender Reason of admission Use of sedation Baseline ventilator settings Days of MV RASS pH PaCO2 (mmHg)
PS level (cmH2O) PEEP level (cmH2O)
1 65 M Postoperative after AAA Haloperidol, sufentanil, midazolam 10 10 8 − 1 7.41 37.5
2 64 F COPD Gold I Haloperidol 10 8 27 0 7.43 51.0
3 70 M Bilateral pneumonia Haloperidol 10 6 22 − 2 7.42 58.5
4 68 M Hypoxemia, suspected aeCOPD Haloperidol 10 5 28 0 7.49 40.5
5 67 M CABG Haloperidol, dexmedetomidine, sufentanil 10 10 21 0 7.50 41.3
6 71 M COPD Gold III Oxazepam 10 5 45 0 7.45 64.5
7 69 M CABG, PJP 8 6 11 − 1 7.42 58.5
8 68 M Pneumonia, COPD Gold III Haloperidol, sufentanil 10 5 3 − 3 7.48 32.3
9 65 M CABG Haloperidol, sufentanil 10 6 19 0 7.52 36.0
10 46 M Bentall procedure Midazolam, sufentanil 10 8 3 − 4 7.36 38.3
11 62 M Septic profile, ARDS Haloperidol, oxazepam, sufentanil 10 6 15 NA 7.44 35.3
12 59 F COPD Gold II Remifentanil 10 5 7 NA 7.43 42.8
13 65 F aeCOPD Gold III Midazolam, sufentanil 10 5 8 − 2 7.48 51.0
14 75 F Hypercapnic coma, weaning problems 0 10 20 0 7.42 50.3
15 52 M Mediastinitis, COPD Gold II Haloperidol 0 8 35 − 2 NA NA
16 69 M aeCOPD Gold III Haloperidol, midazolam, sufentanil 10 5 3 − 2 7.45 42.0
17 47 F Weaning problems 8 5 20 0 7.41 67.5
  1. MV mechanical ventilation, RASS Richmond Agitation-Sedation Scale, PS pressure support, PEEP positive end-expiratory pressure, M male, F female, AAA abdominal aortic aneurysm, COPD chronic obstructive pulmonary disease, CABG coronary artery bypass graft, PJP pneumocystic jirovecii pneumonia, ARDS acute respiratory distress syndrome, NA not available